shot-button
Subscription Subscription
Home > Lifestyle News > Health And Fitness News > Article > Gastric medications may up risk for bacterial infection

Gastric medications may up risk for bacterial infection

Updated on: 28 March,2017 04:50 PM IST  | 
IANS |

People using gastric acid suppression medications may be at a higher risk of bacterium infection that can cause diseases ranging from diarrhoea to life-threatening colon inflammation, researchers, including one of Indian-origin, warned

Gastric medications may up risk for bacterial infection

New York: People using gastric acid suppression medications may be at a higher risk of bacterium infection that can cause diseases ranging from diarrhoea to life-threatening colon inflammation, researchers, including one of Indian-origin, warned.


Infections by Clostridium difficile colitis (C-diff) is caused by disruption of normal, healthy bacteria in the colon, often as a result of antibiotics.


The findings suggest that patients who previously had a case of C-diff and receive gastric acid suppressants may be at increased risk of C-diff recurrence.


"The study found that use of gastric acid suppression medications are associated with a statistically significant increased risk of development of recurrent C-diff in patients with a prior episode of C-diff," said Sahil Khanna, a gastroenterologist at US-based non-profit Mayo Clinic.

For the study, published in JAMA Internal Medicine, the team conducted a systematic review and meta-analysis of 16 studies with 7,703 patients with C-diff and 1,525 of these developed recurrent C-diff.

The researchers analysed gastric suppression medications including proton pump inhibitors, such as omeprazole, and histamine 2 blockers, such as ranitidine, which are commonly prescribed and consumed over-the-counter medications for gastroesophageal reflux disease, peptic ulcer disease or dyspepsia.

The results showed that the rate of recurrent C-diff in patients with gastric suppression was 22.1 per cent, compared to 17.3 per cent in patients without gastric acid suppression.

Thus, "it may be reasonable to re-evaluate the need for these medications in patients with C-diff," Khanna noted.

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!


Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK